News Releases

IBBR HIV Research Published in Cell Reports


April 29, 2019 -- Congratulations to Lin Lei, lead author of a recent study from Dr. Yuxing Li's laboratory. The study, published in Cell Reports, provides new insight into how the immune system responds to HIV. Lei is a graduate student in the UMCP Biological Sciences Graduate Program.

IBBR Investigator to Lead $3.5M NIH-Funded Project to Study Immune Response to HIV-1


Funding will support novel vaccine design aimed at improving protective antibody responses

(Rockville, MD, April 24, 2019) Researchers at the Institute for Bioscience and Biotechnology Research (IBBR) recently received $3.5M from the National Institutes of Health (NIH) to advance understanding of the complex process by which the immune system produces highly specialized antibodies. 

Congratulations to Julia Greenfield for a Successful Dissertation Defense


April 5, 2019 -- Please join us in congratulating Julia Greenfield for successfully defending her dissertation, “Structural and functional studies of tailspike proteins from Escherichia coli O157:H7 phage CBA120."

Congratulations to Xiaoran Shang for a Successful Dissertation Defense


March 12, 2019 -- Please join us in congratulating Xiaoran Shang, from Dr. Daniel Nelson's laboratory, for successfully defending her dissertation. 

IBBR Conference Services: A Resource for the Biotech Community


March 7, 2019 -- The Institute for Bioscience and Biotechnology Research (IBBR) enjoys a prime location in the heart of Maryland's I-270 biotechnology corridor and offers several types of meeting rental space with a focus on the biotechnology sector.

IBBR Participates in NIIMBL-Supported Biomanufacturing Reagent Purification Project


IBBR Emeritus Fellow, Dr. Phil Bryan, and IBBR Fellow, Dr. Eric Toth, Receive NIIMBL Award

February 18, 2019 -- A new award from the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) will support collaborative work on a platform for producing reliable, cost-effective reagents for the manufacture of biotherapeutics.

IBBR Welcomes Dr. Saif Hasan


February 11, 2019 -- IBBR is pleased to extend a warm welcome to Dr. Saif Hasan.  Dr. Hasan joins us as an Assistant Professor in the University of Maryland School of Medicine’s Department of Biochemistry and Molecular Biology. He is a structural biologist who focuses on membrane proteins, and will use IBBR’s new cryo-EM facility to study complexes responsible for biological transport, disease, and virus assembly. 

IBBR Awarded NIH Grant to Investigate T Cell Biology Toward Development of Biotherapeutics


Findings may show how immune checkpoint LAG3 can be exploited to fight disease

(Rockville, MD, January 31, 2019) A team of investigators from the Institute for Bioscience and Biotechnology Research (IBBR) and the University of Pittsburgh recently received a $3.6M National Institutes of Health award to expand the scope of their T cell research involving LAG3 -- a well-known inhibitory receptor on T cells implicated in various cancers, as well as in the chronic infections associated with malaria and HIV.

Congratulations to Dr. Qiong Zhang, Recipient of the UC Berkeley Miller Research Fellowship


January 29, 2019 -- IBBR congratulates Dr. Qiong Zhang as a recipient of the prestigious Miller Research Fellowship, awarded by the Miller Institute for Basic Research in Science at the University of California, Berkeley. Dr. Zhang recently received her Ph.D. in Molecular and Cell Biology from the Biological Sciences Graduate Program (UMCP College of Computer, Mathematical, and Natural Sciences). She worked in the laboratory of IBBR Fellow, Dr. Shunyuan Xiao (Professor, UMCP Department of Plant Science & Landscape Architecture). 

University of Maryland iGEM team, co-advised by IBBR Fellow, Dr. Edward Eisenstein, brings home a gold medal for their innovative plastic waste bioremediation and degradation measurement project


November 30, 2018 -- It takes about 450 years for a plastic bottle to break down in nature, but with the UMD “PETNET” team’s new technology, this time could potentially be cut to as little as 2 weeks.  The team also developed an efficient and economical system to measure degradation.